Table 1.
Prevalence of hypertension and diabetes, and severity and outcomes by comorbidity, in hospitalised patients with confirmed Covid-19.
| Author (Country) | Sample size (n) | Age (yrs) | Hypertension (%) | Diabetes (%) | Hypertension |
Diabetes |
||
|---|---|---|---|---|---|---|---|---|
| Survivor vs Death (%) | Not severe vs Severe (%) | Survivor vs Death (%) | Not severe vs Severe (%) | |||||
| Chen N [6] (China) | 99 | 55.6 | 40.0a | 13.0 | ||||
| Chen T [7] (China) | 274 | 68.0 | 34.0 | 17.0 | 24.0 vs 48.0 | 14.0 vs 21.0 | ||
| Conversano [11] (Italy) | 191 | 63.4 | 50.2 | 14.6 | 42.3 vs 81.0 | 11.4 vs 26.2 | ||
| Guan [2] (China) | 1099 | 47.0 | 15.0 | 7.4 | 13.7 vs 35.8 | 13.4 vs 23.7 | 6.1 vs 26.9 | 5.7 vs 16.2 |
| Guo [8] (China) | 187 | 58.5 | 32.6 | 15.0 | ||||
| Li [9] (China) | 1178 | 55.5 | 30.7 | n/a | ||||
| Mancia [10] (Italy) | 6272 | 68.0 | 57.9b | 19.1b | ||||
| Mehra [12] (Global) | 8910 | 49.0 | 26.3 | 14.3 | 26.4 vs 25.2 | 14.0 vs 18.8 | ||
| Mehta [13] (USA) | 1735 | 49.0 | 78.6 | 38.2 | ||||
| Meng [14] (China) | 417 | 64.5 | 12.2 | n/a | ||||
| Reynolds [15] (USA) | 12,594 | 49.0 | 34.6 | 18.0 | ||||
| Richardson [5] (USA) | 5700 | 63.0 | 56.6 | 33.8 | ||||
| Shi [16] (China) | 416 | 64.0 | 30.5 | 14.4 | ||||
| Wang [17] (China) | 138 | 56.0 | 31.2 | 10.1 | 21.6 vs 58.3 | 5.9 vs 22.2 | ||
| Yang [18] (China) | 52 | 51.9 | n/a | 17.0 | 10.0 vs 22.0 | |||
| Zhang [19] (China) | 140 | 57.0 | 30.0 | 12.1 | 24.4 vs 37.9 | 13.8 vs 11.0 | ||
| Zhou [20] (China) | 191 | 56.0 | 30.0 | 19.0 | 23.0 vs 48.0 | 14.0 vs 31.0 | ||
| Zhu [21] (China) | 7337 | 62 | 24.0 | 12.9 | 2.7 vs 7.8 | |||
a
CVD.
b
on medication for either BP or diabetes.